Company news

Mesoblast Limited news in 2021

Mesoblast Limited's news releases, calls and decks from 2021, newest first.

View company

FDAs OTAT Agrees to Primary Endpoint for Back Pain

December 15, 2021

Update on Novartis Agreement

December 13, 2021

MSB and Oaktree Conclude Refinancing of Senior Debt Facility

November 21, 2021

AHA Late-Breaker - Rexlemestrocel Improves Cardiac Outcomes

November 14, 2021

MSB Annual Financial Results and Operational Progress

August 30, 2021

Mesoblast Update on Chronic Low Back Pain Program

June 30, 2021

MSB Reports Q3 Financial Results and Operational Highlight

June 2, 2021

COVID ARDS Trial Topline 60-Day Results

April 29, 2021

Mesoblast Raises US$110M Led By US Strategic Investor Group

March 1, 2021

Mesoblast Phase 3 Chronic Low Back Pain Results

February 10, 2021

Rexlemestrocel Reduces Heart Attacks/Strokes/CV Death in CHF

January 11, 2021

Decks in 2021